ARTIBANI, Walter
 Distribuzione geografica
Continente #
NA - Nord America 16.796
EU - Europa 13.516
AS - Asia 11.255
SA - Sud America 1.416
AF - Africa 285
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 10
Totale 43.324
Nazione #
US - Stati Uniti d'America 16.436
RU - Federazione Russa 5.456
SG - Singapore 4.374
CN - Cina 3.537
GB - Regno Unito 2.300
IT - Italia 1.181
BR - Brasile 1.080
SE - Svezia 931
VN - Vietnam 904
HK - Hong Kong 903
FR - Francia 860
DE - Germania 746
IE - Irlanda 729
FI - Finlandia 573
KR - Corea 378
BD - Bangladesh 242
CA - Canada 200
UA - Ucraina 192
IN - India 171
JP - Giappone 137
AR - Argentina 123
TR - Turchia 115
MX - Messico 89
NL - Olanda 86
ID - Indonesia 81
ES - Italia 76
ZA - Sudafrica 71
PL - Polonia 66
IQ - Iraq 65
NG - Nigeria 62
BE - Belgio 55
CO - Colombia 46
PK - Pakistan 44
AU - Australia 43
AT - Austria 42
EC - Ecuador 38
MA - Marocco 37
VE - Venezuela 37
SA - Arabia Saudita 32
LT - Lituania 30
PY - Paraguay 28
AE - Emirati Arabi Uniti 26
CL - Cile 26
PH - Filippine 26
CZ - Repubblica Ceca 25
MY - Malesia 24
EG - Egitto 22
IL - Israele 22
KE - Kenya 21
UZ - Uzbekistan 21
TN - Tunisia 20
CH - Svizzera 19
DK - Danimarca 18
PE - Perù 17
JO - Giordania 15
AZ - Azerbaigian 14
LV - Lettonia 14
NP - Nepal 13
PA - Panama 13
UY - Uruguay 12
BG - Bulgaria 11
KG - Kirghizistan 11
DZ - Algeria 10
LB - Libano 10
OM - Oman 10
PT - Portogallo 10
RO - Romania 10
RS - Serbia 10
AL - Albania 9
HR - Croazia 9
HU - Ungheria 9
BO - Bolivia 8
CY - Cipro 8
EU - Europa 8
GR - Grecia 8
IR - Iran 8
JM - Giamaica 8
TT - Trinidad e Tobago 8
AM - Armenia 7
ET - Etiopia 7
GT - Guatemala 7
KZ - Kazakistan 7
SI - Slovenia 7
TH - Thailandia 7
KH - Cambogia 6
LK - Sri Lanka 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
SV - El Salvador 5
TW - Taiwan 5
AO - Angola 4
BB - Barbados 4
BH - Bahrain 4
HN - Honduras 4
MD - Moldavia 4
MT - Malta 4
Totale 43.250
Città #
Singapore 2.364
Ashburn 1.889
Southend 1.888
Moscow 1.674
Chandler 1.611
San Jose 1.420
Jacksonville 1.099
Dallas 1.083
Woodbridge 1.004
Hong Kong 881
Ann Arbor 756
Dublin 728
Beijing 724
The Dalles 611
Houston 540
Verona 527
New York 454
Council Bluffs 378
Los Angeles 346
Wilmington 316
Ho Chi Minh City 310
Lawrence 305
Princeton 305
Jinan 264
Dearborn 222
Nanjing 217
Helsinki 183
Shenyang 166
Hanoi 165
São Paulo 139
Columbus 129
Buffalo 127
Tianjin 127
Tokyo 123
Hebei 120
Redondo Beach 119
Santa Clara 112
Munich 109
Milan 98
Haikou 95
Sindelfingen 93
Montreal 83
Guangzhou 82
Changsha 81
Zhengzhou 81
Orem 80
Ningbo 78
Frankfurt am Main 74
Seattle 67
Fuzhou 65
Nanchang 65
Hangzhou 64
Redwood City 64
Dong Ket 62
London 58
Abuja 56
Warsaw 55
Seoul 54
Jiaxing 53
Taiyuan 53
Falls Church 52
Redmond 52
Denver 51
Brooklyn 50
San Francisco 50
Stockholm 49
Atlanta 48
Boardman 48
Brussels 48
Johannesburg 48
Chicago 47
Volga 47
Chennai 46
Norwalk 45
Phoenix 44
Taizhou 44
Toronto 44
Rome 41
Turku 41
Manchester 39
Amsterdam 37
Jakarta 36
Mexico City 36
Rio de Janeiro 36
Poplar 35
Da Nang 34
Kent 34
Saint Petersburg 32
Haiphong 30
Boston 29
Detroit 27
Ankara 26
Paris 26
Fairfield 25
Baghdad 24
Washington 24
Lanzhou 23
Nuremberg 23
Shanghai 23
Belo Horizonte 22
Totale 26.612
Nome #
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 248
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 245
Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups. 240
PD45-01 ASSOCIATION OF LOCAL ANAESTHETIC WOUNDS INFILTRATION AND ULTRASOUND TRANSVERSUS ABDOMINAL PLANE (US-TAP) BLOCK IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL 234
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 232
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 232
A new training model for robot-assisted urethrovesical anastomosis and posterior muscle-fascial reconstruction: the Verona training technique 231
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 226
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder 225
Argus-T Sling in 182 Male Patients: Short-term Results of a Multicenter Study 221
90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series 219
ROLE OF SYMPTOMS DURATION AS PROGNOSTICATOR FOR SACRAL NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER 219
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 217
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 216
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 215
Adenocarcinoma of the paraurethral glands: a case report 213
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 212
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 211
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 210
Acute Ischemia of the Glans Penis after Circumcision Treated with Hyperbaric Therapy and Pentoxifylline: Case Report and Revision of the Literature 208
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 208
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 204
Liver Metastases From Renal Oncocytoma With Vascular Extension 203
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 203
Association between postoperative thromboembolism prophylaxis and complications following urological surgery 202
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 202
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 201
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 200
A PILOT RANDOMIZED TRIAL OF PREOPERATIVE PELVIC FLOOR MUSCLE EXERCISE VS USUAL CARE TO IMPROVE SEXUAL FUNCTION AND HEALTH RELATED QUALITY OF LIVE AFTER RARP: PRELIMINARY DISAPPOINTED RESULTS 200
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 200
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 200
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 199
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 199
Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study 198
A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. 197
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 197
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 196
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 195
An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity 194
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 194
A case of eosinophilic cystitis in patients with abdominal pain, dysuria, genital skin hyperemia and slight toxocariasis. 192
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 192
MP5-16 QUALITY OF LIFE OF 171 PATIENTS WITH BLADDER CANCER UNDERGOING ILEAL ORTHOTOPIC NEOBLADDER: A MULTICENTRE STUDY AMONG LONG-TERM SURVIVORS 191
Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies 190
Impact of Combination of Local Anesthetic Wounds Infiltration and Ultrasound Transversus Abdominal Plane Block in Patients Undergoing Robot-Assisted Radical Prostatectomy: Perioperative Results of a Double-Blind Randomized Controlled Trial 190
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 189
How radical prostatectomy procedures have changed over the last 10~years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 189
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 188
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 187
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection 185
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer 184
Impact of anatomical pielocaliceal topography in the treatment of renal lower calyces stones with extracorporeal shock wave lithotripsy. 184
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 184
Bone density and skeletal metabolism in patients with orthotopic ileal neobladder. 183
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 183
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE (IPSS) AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 183
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 182
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. 182
MP5-17 QUALITY OF LIFE IN SURVIVORS FROM RADICAL CYSTECTOMY. THE USE OF QUALITATIVE ANALYSIS 180
AR-V7 and prostate cancer: The watershed for treatment selection? 180
COMPLICATIONS AND QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION 179
Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery 179
Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate Cancer 179
Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study 179
HEALTH-RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY IN SURVIVED PATIENTS WITH AN ILEAL CONDUIT OR ILEAL ORTHOTOPIC NEOBLADDER DIVERSION: A COMPARATIVE PROPENSITY-SCORE MATCHED ANALYSIS 179
Mathematical models for prognostic prediction in patients with renal cell carcinoma. 178
Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer 178
External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. 178
Antegrade scrotal sclerotherapy in the treatment of varicocele: a prospective study. 177
High surgeon volume and positive surgical margins can predict the risk of biochemical recurrence after robot-assisted radical prostatectomy 176
Robotic bladder diverticulectomy: step-by-step extravesical posterior approach - technique and outcomes 175
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 175
Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy 175
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 174
Endogenous testosterone as a predictor of prostate growing disorders in the aging male 174
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-oncologico del Nord-est 173
Pain assessment after original transperineal prostate biopsy using a coaxial needle. 172
PURE STRESS URINARY INCONTINENCE: ANALYSIS OF THE PREVALENCE, ESTIMATION OF COSTS AND FINANCIAL IMPACT. 172
Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection 171
A COMPARISON OF VOIDED VOLUMES BETWEEN VOIDING DIARIES AND UROFLOWMETRY 171
43rd Annual Congress of the Italian Urodynamic Society, Rome, Italy, 13th-15th June 2019: Sacral neuromodulation in patients with lower urinary tract symptoms and affected by epilepsy: a multicentre study 170
Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set 169
Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires 168
Continence and complications rates after male slings as primary surgery for post-prostatectomy incontinence: a systematic review. 167
SACRAL NEUROMODULATION FOR THE TREATMENT OF REFRACTORY LOWER URINARY TRACT DYSFUNCTION: RESULTS FROM A MULTICENTER STUDY 167
Late complications after intravaginal slingplasty for female stress urinary incontinence 167
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 167
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer 166
COMPRENSIONE AMBULATORIALE DEL QUESTIONARIO IIEF-5 164
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 164
Modified antegrade scrotal sclerotherapy in adolescent patients with varicocele 163
Prostate specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low risk prostate cancer 163
Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion 163
Advances in Female Urology: A Review of the 2013 Literature 161
Long-term follow-up of anterior vaginal repair: A comparison among colporrhaphy, colporrhaphy with reinforcement by xenograft, and mesh 161
Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy 161
IMPACT OF PREOPERATIVE PATIENTS' CHARACTERISTICS AND FLOW RATE ON FAILURE, EARLY COMPLICATIONS AND VOIDING DYSFUNCTION AFTER TRANSOBTURATORY TAPE PROCEDURE: A RETROSPECTIVE MULTI-CENTRE STUDY 161
Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized Disease 160
Totale 19.043
Categoria #
all - tutte 150.390
article - articoli 139.452
book - libri 0
conference - conferenze 9.775
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.163
Totale 300.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 0 148
2021/20222.299 206 533 28 291 77 62 46 140 81 57 133 645
2022/20234.684 346 395 456 814 392 1.160 48 346 520 29 119 59
2023/20242.358 112 183 172 285 335 355 79 160 26 153 372 126
2024/20256.028 322 445 215 1.066 356 165 251 246 959 382 468 1.153
2025/202618.749 1.262 772 1.203 3.002 4.791 1.340 1.779 974 1.502 1.230 304 590
Totale 43.848